MedTrace Logo

Ultrasound to Assess Sarcopenia in Prader Willi Syndrome

NCT06448871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2024-10-09

No results posted yet for this study

Summary

The aim of the study is to examine the clinical applicability of ultrasound as a diagnostic tool for sarcopenia in individuals with PWS by investigating the association between ultrasound-derived measurements, DXA-derived measurements, and sarcopenia-related outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

Ultrasound assessment of the right lower extremity muscles

Rectus femoris cross sectional area (RFCSA), RF muscle thickness, vastus lateralis (VL) muscle thickness, Gastrocnemius medialis (GM) muscle thickness, VL pennation angle (PA), and GM PA.

DIAGNOSTIC_TEST

Dual-energy X-ray absorptiometry (DXA) scan

skeletal muscle mass (SM), appendicular skeletal muscle mass index (ASMI), total lean body mass (LBM), total fat mass (BF), percentage fat mass, and fat mass index (FMI).

Sponsors & Collaborators

  • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

    lead OTHER

Principal Investigators

  • Valeria Chiu, MD · Taichung Tzu Chi Hospital

Eligibility

Min Age
7 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-17
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06448871 on ClinicalTrials.gov